Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07197684

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Effect of Ultrasound Guided Pecs Block With Intravenous Ketamine and Ketamine Infusion Alone For Prevention of Chronic Post-Surgical Pain in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Aga Khan University · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to is to compare the effectiveness of ultrasound-guided Pecs block with intravenous ketamine versus intravenous ketamine infusion alone in preventing Chronic Post-Surgical Pain (CPSP) in patients undergoing breast cancer surgery. The main question it aims to answer is, How effective is the ketamine and ketamine with pecs block in reducing the frequency of Chronic Post-Surgical Pain after breast cancer surgery

Conditions

Interventions

TypeNameDescription
DRUGKetamineBefore skin incision, a bolus 0.35 mg/kg ketamine will be given followed by a continuous infusion 0.25 mg/kg/hr. Ketamine infusion will be stopped 30 minutes before the end of the surgery
PROCEDUREPecs blockPecs block will be performed before surgical incision with the help of an ultrasound (US) by experienced anesthesiologist. The drug used for the pecs block will be two syringes of 10ml and 20 ml containing bupivacaine 0.25% (total 30 ml).
DRUGNalbuphineIntravenous Nalbuphine 0.1 mg/kg
DRUGParacetamolIntravenous Paracetamol 1g or 15mg/kg (if weight is \< 50kg).

Timeline

Start date
2026-03-16
Primary completion
2026-12-01
Completion
2027-05-01
First posted
2025-09-29
Last updated
2026-02-19

Source: ClinicalTrials.gov record NCT07197684. Inclusion in this directory is not an endorsement.